188 related articles for article (PubMed ID: 24704825)
61. Pivotal role of lnk adaptor protein in endothelial progenitor cell biology for vascular regeneration.
Kwon SM; Suzuki T; Kawamoto A; Ii M; Eguchi M; Akimaru H; Wada M; Matsumoto T; Masuda H; Nakagawa Y; Nishimura H; Kawai K; Takaki S; Asahara T
Circ Res; 2009 Apr; 104(8):969-77. PubMed ID: 19325148
[TBL] [Abstract][Full Text] [Related]
62. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
[TBL] [Abstract][Full Text] [Related]
63. Death domain-associated protein DAXX promotes ovarian cancer development and chemoresistance.
Pan WW; Zhou JJ; Liu XM; Xu Y; Guo LJ; Yu C; Shi QH; Fan HY
J Biol Chem; 2013 May; 288(19):13620-30. PubMed ID: 23539629
[TBL] [Abstract][Full Text] [Related]
64. LNK protein: Low expression in human colorectal carcinoma and relationship with tumor invasion.
Pan J; Peng R; Cheng N; Chen F; Gao B
Biomed Pharmacother; 2020 Jan; 121():109467. PubMed ID: 31706103
[TBL] [Abstract][Full Text] [Related]
65. Role of PELP1/MNAR signaling in ovarian tumorigenesis.
Dimple C; Nair SS; Rajhans R; Pitcheswara PR; Liu J; Balasenthil S; Le XF; Burow ME; Auersperg N; Tekmal RR; Broaddus RR; Vadlamudi RK
Cancer Res; 2008 Jun; 68(12):4902-9. PubMed ID: 18559538
[TBL] [Abstract][Full Text] [Related]
66. Overexpression of E74-Like Factor 5 (ELF5) Inhibits Migration and Invasion of Ovarian Cancer Cells.
Zhang X; Lin J; Ma Y; Zhao J
Med Sci Monit; 2019 Jan; 25():856-865. PubMed ID: 30696803
[TBL] [Abstract][Full Text] [Related]
67. [Effect of Silencing LNK Gene on the Expression of EPO and EPOR in THP-1 Cells].
Tian RM; Luo X; Tan M; Shi L; Huang CS; Su Q; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1013-1019. PubMed ID: 31418350
[TBL] [Abstract][Full Text] [Related]
68. FAM83D inhibits autophagy and promotes proliferation and invasion of ovarian cancer cells via PI3K/AKT/mTOR pathway.
Zhu H; Diao S; Lim V; Hu L; Hu J
Acta Biochim Biophys Sin (Shanghai); 2019 May; 51(5):509-516. PubMed ID: 30939187
[TBL] [Abstract][Full Text] [Related]
69. Lnk/Sh2b3 Regulates Adipose Inflammation and Glucose Tolerance through Group 1 ILCs.
Mori T; Suzuki-Yamazaki N; Takaki S
Cell Rep; 2018 Aug; 24(7):1830-1841. PubMed ID: 30110639
[TBL] [Abstract][Full Text] [Related]
70. Lnk negatively regulates self-renewal of hematopoietic stem cells by modifying thrombopoietin-mediated signal transduction.
Seita J; Ema H; Ooehara J; Yamazaki S; Tadokoro Y; Yamasaki A; Eto K; Takaki S; Takatsu K; Nakauchi H
Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2349-54. PubMed ID: 17284614
[TBL] [Abstract][Full Text] [Related]
71. Hematopoietic and eosinophil-specific LNK(SH2B3) deficiency promotes eosinophilia and arterial thrombosis.
Dou H; Wang R; Tavallaie M; Xiao T; Olszewska M; Papapetrou EP; Tall AR; Wang N
Blood; 2024 Apr; 143(17):1758-1772. PubMed ID: 38096361
[TBL] [Abstract][Full Text] [Related]
72. Ivermectin Augments the In Vitro and In Vivo Efficacy of Cisplatin in Epithelial Ovarian Cancer by Suppressing Akt/mTOR Signaling.
Zhang X; Qin T; Zhu Z; Hong F; Xu Y; Zhang X; Xu X; Ma A
Am J Med Sci; 2020 Feb; 359(2):123-129. PubMed ID: 32039764
[TBL] [Abstract][Full Text] [Related]
73. TNF-alpha induces Lnk expression through PI3K-dependent signaling pathway in human umbilical vein endothelial cells.
Wan M; Li Y; Xue H; Li Q; Li J
J Surg Res; 2006 Nov; 136(1):53-7. PubMed ID: 17007883
[TBL] [Abstract][Full Text] [Related]
74. LNK mutations and myeloproliferative disorders.
McMullin MF; Cario H
Am J Hematol; 2016 Feb; 91(2):248-51. PubMed ID: 26660394
[TBL] [Abstract][Full Text] [Related]
75. LNK deficiency aggravates palmitate-induced preadipocyte apoptosis.
Du JY; Jin CC; Wang GH; Huang XQ; Cheng JD; Wen XJ; Zhao XM; Wang GL
Biochem Biophys Res Commun; 2017 Aug; 490(2):91-97. PubMed ID: 28526415
[TBL] [Abstract][Full Text] [Related]
76. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
Liu X; Li G
Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770
[TBL] [Abstract][Full Text] [Related]
77. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
Kinose Y; Sawada K; Nakamura K; Sawada I; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Takahashi K; Kurachi H; Lengyel E; Kimura T
Oncotarget; 2015 May; 6(13):11342-56. PubMed ID: 25839163
[TBL] [Abstract][Full Text] [Related]
78. WAVE1 gene silencing via RNA interference reduces ovarian cancer cell invasion, migration and proliferation.
Zhang J; Zhou S; Tang L; Shen L; Xiao L; Duan Z; Jia L; Cao Y; Mu X
Gynecol Oncol; 2013 Aug; 130(2):354-61. PubMed ID: 23680521
[TBL] [Abstract][Full Text] [Related]
79. Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells.
Hu C; Huang L; Gest C; Xi X; Janin A; Soria C; Li H; Lu H
J Hematol Oncol; 2012 Jul; 5():16. PubMed ID: 22534171
[TBL] [Abstract][Full Text] [Related]
80. Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells.
Gery S; Xie D; Yin D; Gabra H; Miller C; Wang H; Scott D; Yi WS; Popoviciu ML; Said JW; Koeffler HP
Clin Cancer Res; 2005 Oct; 11(20):7243-54. PubMed ID: 16243794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
